AutoEV on Aplo Scope: High-Throughput, High-Precision EV Analysis Now Within Reach learn more>
Empowering curious minds, transforming discovery
Our mission is to help accelerate human discovery and fight disease by enabling everyone to see and understand the microscopic details of life.
We are dedicated to unlocking the microscopic secrets of life, propelling a new frontier of diagnostics and treatments. Guided by relentless innovation, we continue to develop cutting-edge instruments, applications, and software to fully unleash the potential of super-resolution microscopy. Above all, we remain steadfast in our commitment to democratizing access, ensuring that researchers worldwide can harness the power of our technology for groundbreaking discoveries
Founded in 2016 – ONI, originating as a spin-out from the University of Oxford, was incorporated in February 2016 and commenced trading in May of the same year, focusing on the prime product – the Nanoimager.
Collaborative Discovery (CODI) in 2021 – Our cloud based platform for collaborative image analysis was first introduced in January 2021.
EV Profiler 1 in 2021 – Originally called ‘EasyVisi’, ONI launched its first application kit for extracellular vesicle research – EV Profiler 1.
Series B Funding in 2022 – ONI has announced the close of a $75M Series B fundraising round led by ARCH Venture Partners and Casdin Capital, LLC.
US Expansion to San Diego in 2022 – ONI established its North America headquarters in San Diego, California in August 2022, following a temporary office in La Jolla from April 2021.
dSTORM Kits in 2023 – Launch of our Training Kit™: dSTORM and Application Kit™: dSTORM.
End-to-End Solution for EV Research in 2024 – Launch of our automated sample preparation and fluidics platform, Aplo Flow, and the new Application Kit™: EV Profiler 2.
A New Era in 2025 – ONI launches its newest flagship product, Aplo Scope, a category-defining instrument in super-resolution microscopy.
